401k Plan data: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN plan

D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 401k Plan overview

Plan Name	D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN
Plan identification number	001

D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
Partial participant-directed account plan - Participants have the opportunity to direct the investment of a portion of the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

D & D MOBILE DRUG TESTING, INC. has sponsored the creation of one or more 401k plans.

Company Name: D & D MOBILE DRUG TESTING, INC.

Employer identification number (EIN): 275062651

NAIC Classification: 621900

Additional information about D & D MOBILE DRUG TESTING, INC.

Jurisdiction of Incorporation: New York Department of State

Incorporation Date: 2011-02-18

Company Identification Number: 4057219

Legal Registered Office Address: 1445 NEW YORK AVE.
Nassau
HUNTINGTON STATION
United States of America (USA)
11746

More information about D & D MOBILE DRUG TESTING, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2024-01-01 ANTHONY DI PRIZITO
001 2023-01-01
001 2023-01-01 ANTHONY DI PRIZITO
001 2022-01-01
001 2022-01-01 ANTHONY DI PRIZITO
001 2021-01-01
001 2021-01-01 ANTHONY DI PRIZITO
001 2020-01-01
001 2019-01-01
001 2018-01-01 ANTHONY DI PRIZITO
001 2017-01-01 ANTHONY DI PRIZITO
001 2016-01-01 ANTHONY DI PRIZITO
001 2015-01-01 ANTHONY DI PRIZITO
001 2014-01-01 ANTHONY DI PRIZITO
001 2013-01-01 ANTHONY DI PRIZITO
001 2012-01-01 ANTHONY DI PRIZITO
001 2011-02-18 ANTHONY DI PRIZITO

Financial Data on D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN

Measure	Date	Value
2023 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2023 401k financial data
Total income from all sources	2023-12-31	$60,894
Expenses. Total of all expenses incurred	2023-12-31	$2,769
Benefits paid (including direct rollovers)	2023-12-31	$1,003
Total plan assets at end of year	2023-12-31	$257,939
Total plan assets at beginning of year	2023-12-31	$199,814
Total contributions received or receivable from participants	2023-12-31	$19,875
Expenses. Other expenses not covered elsewhere	2023-12-31	$1,766
Contributions received from other sources (not participants or employers)	2023-12-31	$0
Other income received	2023-12-31	$41,019
Noncash contributions received	2023-12-31	$0
Net income (gross income less expenses)	2023-12-31	$58,125
Net plan assets at end of year (total assets less liabilities)	2023-12-31	$257,939
Net plan assets at beginning of year (total assets less liabilities)	2023-12-31	$199,814
Assets. Value of employer securities	2023-12-31	$123,008
Total contributions received or receivable from employer(s)	2023-12-31	$0
Value of certain deemed distributions of participant loans	2023-12-31	$0
Value of corrective distributions	2023-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2023-12-31	$0
2022 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2022 401k financial data
Total income from all sources	2022-12-31	$-7,935
Expenses. Total of all expenses incurred	2022-12-31	$1,529
Benefits paid (including direct rollovers)	2022-12-31	$0
Total plan assets at end of year	2022-12-31	$199,814
Total plan assets at beginning of year	2022-12-31	$209,278
Total contributions received or receivable from participants	2022-12-31	$17,750
Expenses. Other expenses not covered elsewhere	2022-12-31	$1,529
Contributions received from other sources (not participants or employers)	2022-12-31	$0
Other income received	2022-12-31	$-25,685
Noncash contributions received	2022-12-31	$0
Net income (gross income less expenses)	2022-12-31	$-9,464
Net plan assets at end of year (total assets less liabilities)	2022-12-31	$199,814
Net plan assets at beginning of year (total assets less liabilities)	2022-12-31	$209,278
Assets. Value of employer securities	2022-12-31	$99,749
Total contributions received or receivable from employer(s)	2022-12-31	$0
Value of certain deemed distributions of participant loans	2022-12-31	$0
Value of corrective distributions	2022-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2022-12-31	$0
2021 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2021 401k financial data
Total income from all sources	2021-12-31	$7,767
Expenses. Total of all expenses incurred	2021-12-31	$992
Benefits paid (including direct rollovers)	2021-12-31	$0
Total plan assets at end of year	2021-12-31	$209,278
Total plan assets at beginning of year	2021-12-31	$202,503
Total contributions received or receivable from participants	2021-12-31	$18,000
Expenses. Other expenses not covered elsewhere	2021-12-31	$992
Contributions received from other sources (not participants or employers)	2021-12-31	$0
Other income received	2021-12-31	$-10,233
Noncash contributions received	2021-12-31	$0
Net income (gross income less expenses)	2021-12-31	$6,775
Net plan assets at end of year (total assets less liabilities)	2021-12-31	$209,278
Net plan assets at beginning of year (total assets less liabilities)	2021-12-31	$202,503
Assets. Value of employer securities	2021-12-31	$109,223
Total contributions received or receivable from employer(s)	2021-12-31	$0
Value of certain deemed distributions of participant loans	2021-12-31	$0
Value of corrective distributions	2021-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2021-12-31	$0
2020 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2020 401k financial data
Total income from all sources	2020-12-31	$22,082
Expenses. Total of all expenses incurred	2020-12-31	$476
Benefits paid (including direct rollovers)	2020-12-31	$0
Total plan assets at end of year	2020-12-31	$202,503
Total plan assets at beginning of year	2020-12-31	$180,897
Total contributions received or receivable from participants	2020-12-31	$15,750
Expenses. Other expenses not covered elsewhere	2020-12-31	$476
Contributions received from other sources (not participants or employers)	2020-12-31	$0
Other income received	2020-12-31	$6,332
Noncash contributions received	2020-12-31	$0
Net income (gross income less expenses)	2020-12-31	$21,606
Net plan assets at end of year (total assets less liabilities)	2020-12-31	$202,503
Net plan assets at beginning of year (total assets less liabilities)	2020-12-31	$180,897
Assets. Value of employer securities	2020-12-31	$128,351
Total contributions received or receivable from employer(s)	2020-12-31	$0
Value of certain deemed distributions of participant loans	2020-12-31	$0
Value of corrective distributions	2020-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2020-12-31	$0
2019 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2019 401k financial data
Total plan liabilities at beginning of year	2019-12-31	$0
Total income from all sources	2019-12-31	$-16,194
Expenses. Total of all expenses incurred	2019-12-31	$430
Benefits paid (including direct rollovers)	2019-12-31	$0
Total plan assets at end of year	2019-12-31	$180,897
Total plan assets at beginning of year	2019-12-31	$197,521
Total contributions received or receivable from participants	2019-12-31	$17,000
Expenses. Other expenses not covered elsewhere	2019-12-31	$430
Contributions received from other sources (not participants or employers)	2019-12-31	$0
Other income received	2019-12-31	$-33,194
Noncash contributions received	2019-12-31	$0
Net income (gross income less expenses)	2019-12-31	$-16,624
Net plan assets at end of year (total assets less liabilities)	2019-12-31	$180,897
Net plan assets at beginning of year (total assets less liabilities)	2019-12-31	$197,521
Assets. Value of employer securities	2019-12-31	$128,202
Total contributions received or receivable from employer(s)	2019-12-31	$0
Value of certain deemed distributions of participant loans	2019-12-31	$0
Value of corrective distributions	2019-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2019-12-31	$0
2018 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2018 401k financial data
Transfers to/from the plan	2018-12-31	$0
Total plan liabilities at end of year	2018-12-31	$0
Total plan liabilities at beginning of year	2018-12-31	$0
Total income from all sources	2018-12-31	$19,097
Expenses. Total of all expenses incurred	2018-12-31	$162
Benefits paid (including direct rollovers)	2018-12-31	$0
Total plan assets at end of year	2018-12-31	$197,521
Total plan assets at beginning of year	2018-12-31	$178,586
Total contributions received or receivable from participants	2018-12-31	$15,000
Expenses. Other expenses not covered elsewhere	2018-12-31	$162
Contributions received from other sources (not participants or employers)	2018-12-31	$0
Other income received	2018-12-31	$4,097
Noncash contributions received	2018-12-31	$0
Net income (gross income less expenses)	2018-12-31	$18,935
Net plan assets at end of year (total assets less liabilities)	2018-12-31	$197,521
Net plan assets at beginning of year (total assets less liabilities)	2018-12-31	$178,586
Assets. Value of employer securities	2018-12-31	$167,403
Total contributions received or receivable from employer(s)	2018-12-31	$0
Value of certain deemed distributions of participant loans	2018-12-31	$0
Value of corrective distributions	2018-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2018-12-31	$0
2017 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2017 401k financial data
Total plan liabilities at end of year	2017-12-31	$0
Total plan liabilities at beginning of year	2017-12-31	$0
Total income from all sources	2017-12-31	$29,158
Expenses. Total of all expenses incurred	2017-12-31	$0
Benefits paid (including direct rollovers)	2017-12-31	$0
Total plan assets at end of year	2017-12-31	$178,586
Total plan assets at beginning of year	2017-12-31	$149,428
Total contributions received or receivable from participants	2017-12-31	$15,000
Expenses. Other expenses not covered elsewhere	2017-12-31	$0
Contributions received from other sources (not participants or employers)	2017-12-31	$0
Other income received	2017-12-31	$14,158
Noncash contributions received	2017-12-31	$0
Net income (gross income less expenses)	2017-12-31	$29,158
Net plan assets at end of year (total assets less liabilities)	2017-12-31	$178,586
Net plan assets at beginning of year (total assets less liabilities)	2017-12-31	$149,428
Assets. Value of employer securities	2017-12-31	$161,582
Total contributions received or receivable from employer(s)	2017-12-31	$0
Value of certain deemed distributions of participant loans	2017-12-31	$0
Value of corrective distributions	2017-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2017-12-31	$0
2016 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2016 401k financial data
Transfers to/from the plan	2016-12-31	$0
Total plan liabilities at end of year	2016-12-31	$0
Total plan liabilities at beginning of year	2016-12-31	$0
Total income from all sources	2016-12-31	$-110,068
Expenses. Total of all expenses incurred	2016-12-31	$0
Benefits paid (including direct rollovers)	2016-12-31	$0
Total plan assets at end of year	2016-12-31	$149,428
Total plan assets at beginning of year	2016-12-31	$259,496
Total contributions received or receivable from participants	2016-12-31	$0
Expenses. Other expenses not covered elsewhere	2016-12-31	$0
Contributions received from other sources (not participants or employers)	2016-12-31	$0
Other income received	2016-12-31	$-110,068
Noncash contributions received	2016-12-31	$0
Net income (gross income less expenses)	2016-12-31	$-110,068
Net plan assets at end of year (total assets less liabilities)	2016-12-31	$149,428
Net plan assets at beginning of year (total assets less liabilities)	2016-12-31	$259,496
Assets. Value of employer securities	2016-12-31	$147,425
Total contributions received or receivable from employer(s)	2016-12-31	$0
Value of certain deemed distributions of participant loans	2016-12-31	$0
Value of corrective distributions	2016-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2016-12-31	$0
2015 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2015 401k financial data
Transfers to/from the plan	2015-12-31	$0
Total plan liabilities at end of year	2015-12-31	$0
Total plan liabilities at beginning of year	2015-12-31	$0
Total income from all sources	2015-12-31	$132,600
Expenses. Total of all expenses incurred	2015-12-31	$0
Benefits paid (including direct rollovers)	2015-12-31	$0
Total plan assets at end of year	2015-12-31	$259,496
Total plan assets at beginning of year	2015-12-31	$126,896
Total contributions received or receivable from participants	2015-12-31	$0
Expenses. Other expenses not covered elsewhere	2015-12-31	$0
Contributions received from other sources (not participants or employers)	2015-12-31	$0
Other income received	2015-12-31	$132,600
Noncash contributions received	2015-12-31	$0
Net income (gross income less expenses)	2015-12-31	$132,600
Net plan assets at end of year (total assets less liabilities)	2015-12-31	$259,496
Net plan assets at beginning of year (total assets less liabilities)	2015-12-31	$126,896
Assets. Value of employer securities	2015-12-31	$257,493
Total contributions received or receivable from employer(s)	2015-12-31	$0
Value of certain deemed distributions of participant loans	2015-12-31	$0
Value of corrective distributions	2015-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2015-12-31	$0
2014 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2014 401k financial data
Transfers to/from the plan	2014-12-31	$0
Total plan liabilities at end of year	2014-12-31	$0
Total plan liabilities at beginning of year	2014-12-31	$0
Total income from all sources	2014-12-31	$16,181
Expenses. Total of all expenses incurred	2014-12-31	$0
Benefits paid (including direct rollovers)	2014-12-31	$0
Total plan assets at end of year	2014-12-31	$126,896
Total plan assets at beginning of year	2014-12-31	$110,715
Total contributions received or receivable from participants	2014-12-31	$0
Expenses. Other expenses not covered elsewhere	2014-12-31	$0
Contributions received from other sources (not participants or employers)	2014-12-31	$0
Other income received	2014-12-31	$16,181
Noncash contributions received	2014-12-31	$0
Net income (gross income less expenses)	2014-12-31	$16,181
Net plan assets at end of year (total assets less liabilities)	2014-12-31	$126,896
Net plan assets at beginning of year (total assets less liabilities)	2014-12-31	$110,715
Assets. Value of employer securities	2014-12-31	$124,894
Total contributions received or receivable from employer(s)	2014-12-31	$0
Value of certain deemed distributions of participant loans	2014-12-31	$0
Value of corrective distributions	2014-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2014-12-31	$0
2013 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2013 401k financial data
Total income from all sources	2013-12-31	$-11,329
Expenses. Total of all expenses incurred	2013-12-31	$0
Total plan assets at end of year	2013-12-31	$110,715
Total plan assets at beginning of year	2013-12-31	$122,044
Other income received	2013-12-31	$-11,329
Net income (gross income less expenses)	2013-12-31	$-11,329
Net plan assets at end of year (total assets less liabilities)	2013-12-31	$110,715
Net plan assets at beginning of year (total assets less liabilities)	2013-12-31	$122,044
Assets. Value of employer securities	2013-12-31	$108,715
2012 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2012 401k financial data
Total income from all sources	2012-12-31	$57,044
Expenses. Total of all expenses incurred	2012-12-31	$0
Total plan assets at end of year	2012-12-31	$122,044
Total plan assets at beginning of year	2012-12-31	$65,000
Other income received	2012-12-31	$57,044
Net income (gross income less expenses)	2012-12-31	$57,044
Net plan assets at end of year (total assets less liabilities)	2012-12-31	$122,044
Net plan assets at beginning of year (total assets less liabilities)	2012-12-31	$65,000
Assets. Value of employer securities	2012-12-31	$120,043
2011 : D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2011 401k financial data
Total income from all sources	2011-12-31	$65,000
Expenses. Total of all expenses incurred	2011-12-31	$0
Total plan assets at end of year	2011-12-31	$65,000
Total plan assets at beginning of year	2011-12-31	$0
Contributions received from other sources (not participants or employers)	2011-12-31	$65,000
Net income (gross income less expenses)	2011-12-31	$65,000
Net plan assets at end of year (total assets less liabilities)	2011-12-31	$65,000
Net plan assets at beginning of year (total assets less liabilities)	2011-12-31	$0
Assets. Value of employer securities	2011-12-31	$63,000

Form 5500 Responses for D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN

2023: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2023 form 5500 responses
2023-01-01	Type of plan entity	Single employer plan
2023-01-01	Submission has been amended	No
2023-01-01	This submission is the final filing	No
2023-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2023-01-01	Plan is a collectively bargained plan	No
2023-01-01	Plan funding arrangement – Trust	Yes
2023-01-01	Plan benefit arrangement - Trust	Yes
2022: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: D & D MOBILE DRUG TESTING, INC. 401(K) PROFIT SHARING PLAN 2011 form 5500 responses
2011-02-18	Type of plan entity	Single employer plan
2011-02-18	First time form 5500 has been submitted	Yes
2011-02-18	Submission has been amended	No
2011-02-18	This submission is the final filing	No
2011-02-18	This return/report is a short plan year return/report (less than 12 months)	Yes
2011-02-18	Plan is a collectively bargained plan	No
2011-02-18	Plan funding arrangement – Trust	Yes
2011-02-18	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	D & D MOBILE DRUG TESTING, INC.
Employer identification number (EIN):	275062651
NAIC Classification:	621900

Jurisdiction of Incorporation:	New York Department of State
Incorporation Date:	2011-02-18
Company Identification Number:	4057219
Legal Registered Office Address:	1445 NEW YORK AVE. Nassau HUNTINGTON STATION United States of America (USA) 11746

Plan id#	Filing Submission Date	Name of Administrator
001	2024-01-01	ANTHONY DI PRIZITO
001	2023-01-01
001	2023-01-01	ANTHONY DI PRIZITO
001	2022-01-01
001	2022-01-01	ANTHONY DI PRIZITO
001	2021-01-01
001	2021-01-01	ANTHONY DI PRIZITO
001	2020-01-01
001	2019-01-01
001	2018-01-01	ANTHONY DI PRIZITO
001	2017-01-01	ANTHONY DI PRIZITO
001	2016-01-01	ANTHONY DI PRIZITO
001	2015-01-01	ANTHONY DI PRIZITO
001	2014-01-01	ANTHONY DI PRIZITO
001	2013-01-01	ANTHONY DI PRIZITO
001	2012-01-01	ANTHONY DI PRIZITO
001	2011-02-18	ANTHONY DI PRIZITO